Michael Parkes is a physiologist whose research and teaching has covered a wide range of expertise in physiology, including the endocrine control of fetal growth, sleep and wakefulness in utero, breathing in utero and the initiation of breathing at birth, the effects of temperature on breathing, intracellular recording and labelling of respiratory neurones, hypocapnic apnoea and its effects on the ECG, the effects of hypoxia on brain function, respiratory sinus arrhythmia, the breakpoint of breath-holding and spontaneous sequence analysis of baroreflex sensitivity. He is part of a team using mechanical ventilation and prolonged breath-holding to revolutionize radiotherapy delivery and medical imaging.
Introduction
Many scientific reviews outline the major difficulty in providing any coherent explanation of one of the simplest and vital control systems in physiology, i.e. how well breathing matches metabolic rate (the rate of oxygen consumption) between rest and maximal exercise (Comroe, 1964 (Comroe, , 1974 Dejours, 1964; Ward, 1994; Dempsey et al. 1995 Dempsey et al. , 2014 Waldrop et al. 1996; Forster & Pan, 1997; Dempsey & Whipp, 2003; Prabhakar & Peng, 2004; Forster, 2007 Forster, , 2014 Poon et al. 2007; Forster et al. 2012; Kumar & Prabhakar, 2012; Parkes, 2013; Paterson, 2014) . There are difficulties too in the proposal that matching is explained only by combining more than one mechanism, in either an additive or a multiplicative manner (Comroe, 1974; Cunningham, 1987; Parkes, 2013; Paterson, 2014) . After nearly 100 years of research, either a completely new discovery awaits us or there may be better interpretations of published data.
The simplest assumption is that there is a metabolic rate (oxygen) sensor somewhere and that this ultimately controls breathing. The systemic veins (and/or veins in the skeletal muscle itself) are the obvious sites to locate the metabolic rate sensor(s). It has long been known (Bock et al. 1928 ) that in humans the partial pressure of oxygen in systemic venous blood (P vO 2 ) decreases linearly ( Fig. 1B ) in proportion to metabolic rate (Mitchell et al. 1958; Edwards et al. 1972; Casaburi et al. 1989; Sun et al. 2001) and that of carbon dioxide (P vCO 2 ) increases linearly ( Fig. 1A ) in proportion to metabolic rate. These changes are sustained as long as metabolic rate is increased. Moreover, there are two reasons why the CNS does not need simultaneous measures of both arterial and venous blood gases to measure metabolic rate: (i) the CNS could safely assume normal arterial partial pressures of oxygen and carbon dioxide (P aO 2 and P aCO 2 ) because P aO 2 does not fall and P aCO 2 does not rise during exercise (Fig. 1A and B) ; and (ii) it is already known that removal of such arterial measurements (carotid arterial chemoreceptor denervation) has little effect on the matching of breathing to metabolic rate during exercise in humans (Wasserman et al. 1975b; Honda et al. 1979a) . Thus, combining the venous blood gas signal alone with knowledge of cardiac output could enable the CNS to estimate metabolic rate continuously for matching.
The idea of metabolic rate sensors in the systemic venous system was implied at least as early as 1886 and was last resurrected by Riley and colleagues (Dutton et al. 1960; Riley et al. 1960 Riley et al. , 1963 Armstrong et al. 1961; Riley, 1963) . Despite the undisputed existence of such an obvious metabolic rate signal, the particular problem is that nobody has yet succeeded in demonstrating whether it is used, i.e. that venous chemoreceptors either do or do not exist. One negative study in humans (Dejours et al. 1955 ) is often cited. Dejours wrote the series of reviews (Dejours, 1962 (Dejours, , 1963 (Dejours, , 1964 cautiously proposing that 'such chemoreceptors do not seem to exist' , to which many articles defer.
But Dejours et al. (1955) is directly contradicted by a previous study (Mills, 1944) that is not cited. Given that neither study has been independently validated, 'absence of evidence is not evidence of absence' (Sagan, 1980) , and the better judgement is 'inconclusive' . In which case, venous chemoreceptors could explain matching all the time, but we fail to see them.
Failure of carotid and aortic (arterial) or central chemoreceptors to explain matching
Corneille Heymans won the 1938 Nobel prize in Physiology or Medicine for the discovery of arterial chemoreceptors. These have dominated all thinking about the control of breathing ever since. Yet the following three sets of experiments in humans show that they cannot act as metabolic rate sensors (Forster et al. 2012; Kumar & Prabhakar, 2012; Parkes, 2013 Parkes, , 2014 Dempsey et al. 2014; Forster, 2014) .
(i) Figures 1 and 2 show that the arterial chemoreceptors are in the wrong location to measure metabolic rate, as they receive no known blood-borne signal related Systemic venous chemoreceptors and breathing in humans PvCO2 rises linearly with metabolic rate during exercise (unlike PaCO2).
PvO2 falls linearly with metabolic rate during exercise (unlike PaO2). . Systemic venous (but not arterial) blood gas levels change in proportion to metabolic rate A, the venous partial pressure of carbon dioxide (P vCO 2 ) increases linearly with metabolic rate during exercise [unlike the arterial partial pressure of carbon dioxide (P aCO 2 )]. Mean ± SEM P aCO 2 (brachial artery) and mixed venous P vCO 2 (pulmonary artery) during incremental exercise to maximum, normalized to their mean lactic acidosis threshold (LAT) of 2.0 ± 0.0 l O 2 min −1 (0.7 kW) in five healthy subjects. B, the venous partial pressure of oxygen (P vO 2 ) decreases linearly with metabolic rate during exercise [unlike the arterial partial pressure of oxygen (P aO 2 )]. Mean ± SEM P aO 2 (brachial artery) and mixed venous P vO 2 (pulmonary artery) during incremental exercise to maximum, normalized to their mean LAT of 2.0 ± 0.0 l O 2 min −1 (0.7 kW) in five healthy subjects. Blood O 2 content (mM) = (1.34 × [Hb] × percentage arterial oxygen saturation + 0.00326 P O 2 mmHg)/2.226. Reproduced with permission from Sun et al. (2001) .
to metabolic rate (P aCO 2 fails to rise and P aO 2 fails to fall during exercise).
(ii) Their severest stimulation by hypoxia, to levels that can cause unconsciousness, fails to increase breathing to anywhere near the levels seen at maximal exercise (Dripps & Comroe, 1947; Parkes, 2013) . (iii) Bilateral denervation of carotid chemoreceptors has remarkably little effect on breathing in humans at rest or during exercise (Lugliani et al. 1971; Wasserman et al. 1975b; Honda et al. 1979a) .
Even evidence for arterial chemoreceptors routinely acting as 'mismatch sensors' or 'fine-tuning' breathing if it ever fails to match metabolic rate is not easily obtained (Dripps & Comroe, 1947; Lambertsen et al. 1953; Dejours et al. 1958; Forster & Pan, 1994; Parkes, 2013) . Neither is there evidence in humans that aortic or central chemoreceptors could be the metabolic rate sensor, because they too receive no blood-borne (or other) signal linked to metabolic rate.
Arterial chemoreceptors undoubtedly do provide powerful and rapid warning about the chemical composition of blood supplying the brain. But even when hypoxia stimulates breathing, this has only limited benefit. This hyperventilation itself uses up more oxygen. Moreover, all it achieves is raising alveolar P O 2 by 1 mmHg for every 1 mmHg that it lowers alveolar P CO 2 (Luft, 1965) , so at best it can increase the partial pressure gradient driving oxygen from the lungs into the bloodstream only by ß27 mmHg (Malconian et al. 1993) . There is also much interest in their potential to drive maladaptive cardiorespiratory outcomes (e.g. hypertension) in disease. But something else is responsible for measuring metabolic rate. Recent experimental evidence continues to emphasize important roles for chemoreceptor feedback, now from muscle (Cui et al. 2011; Kaufman, 2012) , and of afferent feedback from both muscle and the peripheral vasculature, in driving both the cardiovascular and respiratory systems (Dempsey et al. 2014; Haouzi, 2014; Paterson, 2014 ). Yet apparently because of the Dejours reviews, the possibility that venous chemoreceptors might account for some of these intriguing observations is not currently considered.
Chemoreceptor-like anatomical structures exist in the venous system
Carotid chemoreceptors belong to a general class of anatomical structures known as paraganglia, which are groups of neurons outside the CNS believed to derive from the sympathetic nervous system (Bock, 1982) . All paraganglia are believed to be chemoreceptors for O 2 and CO 2 , but the function of almost all of them is unknown. They are almost invisible to the naked eye, and their characteristic chromaffin granules are not easily visible even with a light microscope (Bock, 1982) . Intriguingly, the carotid bifurcation in humans is not the only location where paraganglia are found (Comroe, 1964; Bock, 1982) . Not only are paraganglia found in the human aortic arch (Comroe, 1964) , these apparently having no respiratory function in humans (Parkes, 2013) , but also around the vagus nerves, some veins and pelvic viscera (Bock, 1982) . They may be even more widespread in the systemic venous system, but we do not yet have an anatomical means of addressing this in humans using only post-mortem material. Yet encouragingly, even in 2016, there is precedent for the discovery of new organs (Coffey & O'Leary, 2016) .
In mammals other than humans, there has always been dispute (Bock, 1982) between the anatomical and functional identification of venous chemoreceptors. For example, an anatomical study in cats published in Nature (Hughes, 1965; Comroe, 1974) claimed to have discovered pulmonary chemoreceptors for systemic, mixed venous blood. A letter disputed this (Coleridge et al. 1966) . Later, one functional study failed to detect chemoreceptor-like activity when recording from some pulmonary vagal afferent nerves in anaesthetized cats (Coleridge et al. 1967) , despite an earlier functional study claiming to have found them (Duke et al. 1963) . There is early work in anaesthetized dogs and, more recently, rats, describing afferent neurones with chemoreceptor-like activity (i.e. stimulated by hypoxia), originating in the abdomen (i.e. outside the classical carotid and aortic regions), that are capable of stimulating breathing (Bean, 1952; Howe et al. 1981; Child et al. 1990; Howe, 1990) . But none of these studies is definitive nor have they been pursued further.
Stimulation as the main tool to search for functional venous chemoreceptors
The classical scientific approaches to search for venous chemoreceptors are recording, ablation and stimulation Diagram of typical values of systemic arterial P aCO 2 and mixed P vCO 2 in man at rest (A) and maximal exercise (B), with data from multiple sources including Wasserman et al. (1994) .
Comparison of A and B shows that systemic arterial chemoreceptors are in the wrong place to measure metabolic rate or metabolically produced CO 2 , because O 2 from air is carried from the lungs to tissues without P aO 2 decreasing. Likewise, metabolically produced CO 2 is carried via the systemic veins from muscle to air without P aCO 2 increasing. In contrast, systemic venous chemoreceptors are in the right place to measure metabolic rate. Reproduced with permission from Parkes (2013 Parkes ( , 2014 . (Walshe, 1951; Cohen & Wang, 1959; Stein & Stoodley, 2006; Parkes, 2013) . Nobody yet has 'recorded' the sensitivity to hypoxia and hypercapnia of paraganglia other than those of the arterial chemoreceptors in the carotid bifurcation and aortic arch (Torrance, 1996) . Such descriptions of the properties of the arterial chemoreceptors are invaluable. But if venous chemoreceptors exist, the range and time course of blood gas changes to which they are exposed are very different, so their responses too would be very different. Presently, 'recording' can only be established indirectly from sampling the composition of venous blood. Figure 1 confirms that the operating range to which venous chemoreceptors would be exposed is very different and, more importantly, that appropriate changes in both P O 2 and P CO 2 , in proportion to changes in metabolic rate, are already present.
'Ablation' is difficult; venous chemoreceptors have not been found, so we do not know what nervous structures to ablate. If widespread, we may guess that their afferent pathways might include the spinal cord in addition to some cranial nerves. So 'ablation' here can consider the implications for their existence of experiments in humans involving spinal anaesthesia and paraplegia.
So far, 'stimulation' (applying hypoxia, hypercapnia, asphyxia or occlusion cuffs) is the principal scientific approach used to search for venous chemoreceptors.
Some of the basic principles for evaluating experimental evidence (Parkes, 2013 ) also need reiteration here, in particular the need for independent verification of the key experiments (at least two citations for each), for validation of negative results and to put stimulation experiments in the context of maximal metabolic rate being at ß5.6 l O 2 min −1 (ß1.9 kW) in exercise (ß400 W of external work), with maximal breathing at ß100-150 l min − 1 . Here, the useful terminology for quantifying breathing is as minute ventilation (V E ; in litres per minute), for exercise and for metabolic rate is as litres of O 2 per minute or in watts, with external work as watts of external work (W ew ) and for variance in the data as ±SEM.
Initial but misleading preconceptions about venous chemoreceptors
In order to achieve matching, the control system needs a sensor to measure metabolic rate (rate of O 2 consumption) continuously. This would then drive breathing appropriately between rest and maximal exercise. What is known about chemoreception to O 2 and CO 2 in general is derived principally from studying carotid chemoreceptors. This has led to the obvious preconception that venous chemoreceptors must have similar properties, i.e. that stimulation of one discrete population of chemoreceptors (for humans, only the carotid chemoreceptors), at one bilateral location (the carotid bifurcation), produces a substantial and rapid stimulation of breathing (typically within ß1 s; Cropp & Comroe, 1961) .
Applying this preconception to systemic venous chemoreceptors proposes that one population, located only at or near the right atrium and/or in the pulmonary artery, could estimate the metabolic rate of the whole body by sampling the composition of mixed venous blood and stimulating breathing immediately. It should be easy to reveal this population, by testing whether appropriate stimuli applied here stimulate breathing substantially and immediately. The failure of such 'easy experiments' to produce unambiguous and positive results (a stimulation of breathing) revealing this population has contributed to the apparent dismissal of venous chemoreceptors. But this preconception is misleading. There are many reasons that would account for such negative results while remaining consistent with the existence of venous chemoreceptors.
The ideal stimulus, its duration and location, to reveal venous chemoreceptors
Venous chemoreceptors could have three properties radically different from this preconception of one population at one location. These were not taken into account in the original evaluation of these 'easy experiments' (e.g. Dawes & Comroe, 1954) and would explain why venous chemoreceptors could be much more difficult to find.
First, venous chemoreceptors might instead be located at multiple locations along the systemic venous side, anywhere between each skeletal muscle and the right heart (Fig. 2) . Thus, the ideal stimulus would need to be applied at as many locations as possible from muscle to the right heart to produce a big (and therefore detectable) stimulation of breathing. The CNS would derive metabolic rate by adding or multiplying these many chemoreceptor signals with appropriate weighting. This would provide the ideal graded stimulation of breathing that perfectly matches the number of metabolically active muscles and would explain how breathing matches metabolic rate so well. This would also explain why venous chemoreceptors are so difficult to find experimentally; because there are few at any one location, they are difficult to reveal. Even maximal stimulation at only one location (or ablation at one location) might barely increase (or ablation barely decrease) breathing sufficiently to be noticed.
Secondly, we accept the importance of the rapid breathing response (within 1 s) to carotid chemoreceptor stimulation. This is because if arterial blood gas levels ever do change in a threatening direction, this represents an immediate threat to the brain. But the breathing response to venous chemoreceptor stimulation may not, and need not, be so rapid because of a combination of the following two factors: (i) the metabolic rate of the whole body (and consequently, venous blood gas levels) does not normally change within 1 s, so their natural stimulus could take more time to build up; and (ii) it may take longer for the CNS to integrate the inputs from multiple venous chemoreceptor sites (also, venous chemoreceptors might just respond more slowly).
Thus, the duration of the ideal stimulus for venous chemoreceptors should be much longer than 1 s. Providing a sustained stimulus that is isolated solely to the venous side from muscle to the right heart, is technically not straightforward and has not yet been attempted. Furthermore, this duration issue also exposes the difficulty in interpreting the 'easy' and classical studies infusing hypoxic or hypercapnic venous blood at the right atrium (e.g. Cropp & Comroe, 1961; Sylvester et al. 1973) . If a slow breathing increase in response to venous chemoreceptor stimulation overlapped with the more rapid breathing response once such blood reached the arterial chemoreceptors, the arterial chemoreceptor response would 'interpretatively' mask any venous chemoreceptor response. Thus, the observed response might not represent solely that of arterial chemoreceptors, and distinction of these two possibilities requires repeating these experiments after arterial chemoreceptor denervation.
Thirdly, given that both P vCO 2 and P vO 2 always change as metabolic rate changes (i.e. in the direction of asphyxia), the ideal stimulus to reveal venous chemoreceptors should be simultaneously to lower P vO 2 and to increase P vCO 2 to their levels at maximal exercise. It is already known that changing both simultaneously is a better stimulus than the simple sum of either alone to the arterial chemoreceptors (Torrance, 1996) and to increase breathing (Nielsen & Smith, 1951; Cormack et al. 1957; Lloyd, 1965; Bernards et al. 1966; Comroe, 1974; Swanson & Bellville, 1974; Teppema & Dahan, 2010) . But this ideal stimulus has not yet been applied systematically in the search for venous chemoreceptors.
These three points could explain why venous chemoreceptors have not yet been seen; applying the wrong stimulus at the wrong location and for the wrong duration.
The residual stimulation of breathing by hypoxia in sino-aortically denervated animals
If arterial chemoreceptor denervation completely abolishes all stimulation of breathing by hypoxia (i.e. if the breathing increase is now zero in every subject), then venous chemoreceptors cannot be the metabolic rate (oxygen) sensor. But it has always been known that there is still a residual stimulation of breathing by hypoxia after arterial chemoreceptor denervation. Its mechanism has never been explained. Heymans et al. (1930) described this residual response in their original discovery of the arterial chemoreceptors (see Fig. 3 ) and deliberately confirmed it subsequently in awake dogs (Cordier & Heymans, 1935; Bouckaert et al. 1938) . Although others have not seen this, neither were they looking for it (Wright, 1936; Dumke et al. 1941; Bjurstedt, 1946; Gernandt, 1946) . But many other independent studies confirm the existence of a residual response (Schmidt, 1932; Selladurai & Wright, 1932; Decharneux, 1934; Jongbloed, 1936; Marshall & Rosenfeld, 1936; Gesell & Moyer, 1937; Smyth, 1937; Comroe, 1939; Schmidt & Comroe, 1940; Moyer & Beecher, 1942; Watt et al. 1943; Davenport et al. 1947) : 'an increase in respiration sometimes occurred during systemic anoxemia even after denervation of the carotid and aortic chemoreceptors' (Comroe, 1939) ; and ' Heymans et al. found . . . that section of the sinus and depressor nerves changed the violent hyperpnea and marked hypertension produced by nitrogen inhalation into a very slight respiratory stimulation and a relatively small rise in blood pressure . . . instances are not lacking . . . of a distinct anoxemic hyperpnea remaining after section of the sinus and depressor nerves' (Schmidt & Comroe, 1940) .
They were also fully aware of its importance in suggesting that chemoreceptors, other than arterial, mediate the stimulation of breathing by hypoxia. Thus: r 'in unanesthetized dogs . . . after denervation . . . depression of depth and rate . . . was succeeded by acceleration of rate. Therefore known chemoreceptor reflexes cannot be responsible for all the increase in rate during prolonged anoxia' (Watt et al. 1943);  r 'and after removal of all known chemoreceptors by additional section of the aortic nerves, anoxemia still produced the same acceleration . . . . If all means of peripheral chemical excitation are thus removed how then was acceleration produced?' (Gesell & Moyer, 1937) ; r 'The possibility that the stimulation of respiration attending hypoxia, in the absence of carotid and aortic and possibly pulmonary chemoreceptor innervation, may be due to unknown chemoreceptive mechanisms cannot be ruled out by these experiments' (Moyer & Beecher, 1942) ; and r 'some mechanism other than the carotid and aortic bodies causes delayed tachypnea in lightly anaesthetized or unanesthetized animals. Another mechanism may also be involved in the hyperpnea of chronic anoxemia . . . . This could represent central stimulation by anoxia (concomitant with central depression), reflex stimulation from an unidentified group of peripheral chemoreceptors . . . ' (Comroe, 1964) .
Later, its description disappears (Cropp & Comroe, 1961; Sylvester et al. 1973) . But it resurfaces (Comroe, 1974; Miller & Tenney, 1975; Gautier & Bonora, 1980) , and there may be allusion in Teppema & Dahan (2010) .
One possibility is that this residual breathing response to hypoxia is mediated by venous chemoreceptors. Its effect on breathing may appear small only because the ideal stimulus, duration and location to reveal venous chemoreceptors have yet to be applied.
The residual stimulation of breathing by hypoxia in humans after arterial chemoreceptor denervation
The common misconception that in humans only carotid chemoreceptors (Parkes, 2013) mediate the breathing response to hypoxia arises from the belief that hypoxia supposedly produces no increase (i.e. an increase in breathing of zero) after carotid chemoreceptor denervation in humans (Lugliani et al. 1971; Honda et al. 1979b; Dahan et al. 2007) . And because temporary sino-aortic blockade in only two subjects (Guz et al. 1966) apparently produced no further deficits in breathing than carotid chemoreceptor denervation alone, thereby eliminating any stimulation of breathing by aortic chemoreceptors in humans (Lugliani et al. 1971; Honda et al. 1979b; Wasserman et al. 1994; Parkes, 2013) .
But for two reasons this is a misconception. Firstly, some studies do confirm the presence of some residual breathing sensitivity (or an enhancement of kinetics) to hypoxia in bilaterally carotid chemodenervated patients (Guz et al. 1966; Wade et al. 1970; Swanson et al. 1978; Bellville et al. 1979; Honda et al. 1979b; Honda, 1992; Whipp et al. 1994) . Furthermore, this arises too quickly to be caused by central chemoreceptors (Swanson et al. 1978) .
Secondly, in most of these studies the level of hypoxia applied may not always have been intense enough to reveal definitively whether or not this residual response exists. The inspired oxygen level apparently needs to be lowered to <9% (Dripps & Comroe, 1947; Comroe, 1964) , i.e. apparently to a P aO 2 of ß<40 mmHg (Parkes, 2013) , 
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before substantial stimulation of breathing is evident. But in chemodenervation studies such levels levels of hypoxia may not always have been applied (Lugliani et al. 1971; Honda et al. 1979b; Dahan et al. 2007) .
Some (e.g. Honda et al. 1979b) suggest that this residual stimulation in humans might be attributable to regrowth and re-innervation of carotid chemoreceptor tissue. But such regrowth is impossible when residual stimulation is detected immediately after sino-aortic denervation (Schmidt & Comroe, 1940) . Furthermore, explaining the residual stimulation by the presence of additional chemoreceptors (e.g. venous chemoreceptors) is as valid as by re-innervation of denervated chemoreceptors. There is no experimental evidence yet to distinguish between these two explanations.
How does CO 2 stimulate breathing after arterial chemoreceptor denervation?
Central chemoreceptors for CO 2 do exist, and their stimulation does stimulate breathing (Heymans et al. 1930; Cordier & Heymans, 1935; Dejours, 1962; Ballantyne & Scheid, 2000) .
There is also a common misattribution that all breathing responses to raised P CO 2 (hypercapnia) remaining after arterial chemoreceptor denervation are caused solely by central chemoreceptors. This is a misattribution because nobody yet has confirmed that ablation of central chemoreceptors abolishes this remaining breathing response to hypercapnia (Schlaefke et al. 1974 (Schlaefke et al. , 1979 Spode & Schlaefke, 1975; Schlaefke, 1981; Whipp, 1983) . Neither can central chemoreceptors account for the continued matching of breathing with metabolic rate after bilateral carotid denervation in humans, because they have no means of sensing metabolic rate.
This misattribution has two important implications for venous chemoreceptors. Firstly, it implies, without ever establishing, that venous chemoreceptors cannot mediate any of the stimulation of breathing by raised P CO 2 . Secondly, it creates an interpretative problem that discourages further 'stimulation' experiments to search for venous chemoreceptors using their ideal stimulus of combined hypoxia and hypercapnia and after arterial chemoreceptor denervation. Any detectable stimulation of breathing is attributed solely to CO 2 stimulating central chemoreceptors, whereas it could equally represent some stimulation of venous chemoreceptors. This misconception continues to hinder the search for venous chemoreceptors.
How would we know if we had discovered venous chemoreceptors?
The ideal stimulation experiment would be to induce, in resting subjects for a sustained period, the venous P O 2 and P CO 2 levels attained during maximal exercise, without simultaneously changing their systemic arterial levels. At present, this is technically too difficult to achieve, the nearest being the sudden release of occlusion cuffs, described below. (It might also be useful to change both systemic venous and arterial P O 2 in carotid sinusdenervated patients, but this straightforward experiment is yet to be undertaken.)
The ideal positive result is that such stimulation increases breathing to the levels of maximal exercise (e.g. ࣙ100 l min −1 in humans), followed up by independent confirmation and appropriate outcomes from 'ablation' and 'recording' experiments (Parkes, 2013) .
How would we know if we had established that venous chemoreceptors do not exist?
The ideal negative is to show zero change in breathing following the ideal venous stimulus and or a complete abolition of any increase in breathing by denervation of arterial and central chemoreceptors. There are two common approaches that fail to validate the negative result: (i) the 'hyperoxia argument' , abolishing any response by applying hyperoxia is inadequate (because this might simply weaken any venous chemoreceptor response); and (ii) the 'response time argument' , demonstrating breathing increases only after the stimulus could have reached the carotid or central chemoreceptors (because a breathing response to their stimulation might overlap with a slower breathing response to venous chemoreceptor stimulation).
The following paragraphs show how stimulation experiments in both humans and other mammals fail to establish the existence of venous chemoreceptors, but neither do they establish that venous chemoreceptors do not exist.
Inconclusive stimulation experiments in animals for cardiopulmonary venous chemoreceptors
The early literature (with animals, not humans, and with anaesthesia) that could not find venous chemoreceptors is inconclusive because these 'easy experiments' were incomplete and focused only on the right heart and pulmonary arteries (Dawes & Comroe, 1954; Aviado & Schmidt, 1955; Cropp & Comroe, 1961; Comroe, 1974) . They did not undertake a systematic and exhaustive search for them by applying the ideal stimulus, duration and location between muscle and the right heart. r Heymans originally discovered the carotid chemoreceptors in dogs only by accident (Heymans, 1967) , and his research thereafter appears to have concentrated on these, rather than searching for more. Systemic venous chemoreceptors and breathing in humans r Even this early literature (Dawes & Comroe, 1954; Aviado & Schmidt, 1955; Cropp & Comroe, 1961; Sylvester et al. 1973; Comroe, 1974) contains ambiguities that indicate something else might be present. For instance, Aviado & Schmidt (1955) (Haouzi et al. 1995 (Haouzi et al. , 2005 Haouzi & Bell, 2010) . The proposed mechanism includes involvment of distension of the veins (Haouzi, 2014) . It is also possible that venous chemoreceptors make a contribution.
r To interpret the results of cyanide or phenyl diguanide infusions in these 'easy experiments' (Dawes & Comroe, 1954; Comroe, 1974) , the 'response time argument' was applied, whose weakness is explained above.
Inconclusive stimulation experiments for venous chemoreceptors in animals between muscle and the right atrium
Some cross-circulation experiments did find evidence for the existence of venous chemoreceptors [breathing increased in anaesthetized resting (recipient) dogs when venous blood from the hind legs of 'exercised' (donor) dogs was returned to the recipient's iliac vein (Kao & Ray, 1954; Riley, 1963) ]. But these experiments were done under anaesthesia, at low 'exercise' intensities (Forster & Pan, 1997) , the crucial time intervals are not reported and results are not consistent between different experiments (Kao, 1956 (Kao, , 1963 (Kao, , 1974 Kao et al. 1963 Kao et al. , 1964 Forster & Pan, 1997) .
Attempts have also been made in anaesthetized (Wasserman et al. 1975a) or unanaesthetized animals (Yamamoto & Edwards, 1960; Phillipson et al. 1981a,b,c) , to test whether raising only systemic P vCO 2 can stimulate breathing without raising P aCO 2 (hence, without involving arterial and central chemoreceptors). One purpose was to test the possibly that breathing might be controlled only from CO 2 (the 'CO 2 flow' hypothesis). But another equally valid possibility is that such experiments partly stimulate venous chemoreceptors. Indeed, if so, the better experiment would be simultaneously to increase systemic P vCO 2 and lower systemic P vO 2 , the ideal venous chemoreceptor stimulant (and again without altering P aCO 2 or P aO 2 ). In any event, the interpretation of the results of such experiments remains controversial (Dempsey et al. 2014) . The arterial blood sampling regimens were not frequent enough to establish convincingly that no P aCO 2 increase occurred, and arterial chemoreceptor denervation was not always applied. Interestingly, some acknowledged that they were unable to rule out venous chemoreceptors.
Inconclusive stimulation experiments in humans for venous chemoreceptors within skeletal muscle
Venous chemoreceptors might exist even within skeletal muscle (and within other organs), because muscle contributes most to the increased metabolic rate of exercise. It has been known since the 1930s (Alam & Smirk, 1937; Coote et al. 1971; Rowell et al. 1976; Rowell & O'Leary, 1990; Fisher & White, 2004 ) that stimulation of chemoreceptors within skeletal muscle increases blood pressure (a 'pressor response'). The receptors mediating this pressor response are termed here 'muscle metaboreceptors' to distinguish them from putative muscle/venous chemoreceptors that might stimulate breathing. These muscle metaboreceptors are revealed by inflating an occlusion cuff wrapped round exercising limbs during exercise to trap metabolites within the muscle. When the exercise is stopped but the cuff remains occluded ('postexercise occlusion'), the trapped metabolites stimulate muscle metaboreceptors that in turn sustain a pressor response at or above its exercise level until the cuff is released (see Fig. 3 of Rowell et al. 1976) .
Applying the same technique should also reveal whether muscle metabolites stimulate breathing. The cuff could be inflated either during exercise (ideally at high, but not maximal, intensity) or after maximal exercise stops (postexercise occlusion). A positive result occurs if occlusion further stimulates breathing during exercise and/or sustains breathing postexercise at its exercise level for as long as occlusion is maintained. (The further importance of releasing the postexercise occlusion cuff is considered later.)
The problem, however, is in validating the negative result (no stimulation of breathing) to establish that muscle chemoreceptors cannot stimulate breathing. A major difficulty is in ensuring that no blood leaked round the cuff and thus weakened the stimulation. This may well occur, because the pressor response can decrease while cuff inflation is maintained (Crisafulli et al. 2008) . There are two reasons why the negative result is not validated simply by confirming that postexercise occlusion sustains some sort of pressor response. Firstly, if some of the trapped metabolites had leaked out, the remnant might be sufficient to provoke a pressor response but insufficient to produce a detectable effect on breathing. Secondly, the venous chemoreceptors that stimulate breathing might be different chemoreceptors from muscle metaboreceptors; hence, the pressor response does not reflect their response.
The key validation (yet to be applied) is to demonstrate complete retention of a tracer (a dye or CO 2 itself) within the occluded limb, or that CO 2 production at the mouth is decreased by exactly the amount expected from the total amount of CO 2 produced (but trapped) within the limb.
Overall, the occlusion studies on humans during exercise are inconclusive (Dempsey et al. 2014) . Some find no effect on breathing (Asmussen et al. 1943; Dejours et al. 1957; Rowell et al. 1976) or an increase (Comroe & Schmidt, 1943; Sargeant et al. 1981) or a decrease (Barman et al. 1943) .
Twelve out of 13 studies report that occlusion fails to stimulate breathing during exercise and/or fails to sustain breathing postexercise at its exercise levels (Wiley & Lind, 1971; Rowell et al. 1976; Fordyce et al. 1982; Innes et al. 1989; Haouzi et al. 1993 Haouzi et al. , 2001 Scott et al. 2000; Fukuba et al. 2007; Lykidis et al. 2010; Olson, 2010; Bruce & White, 2012 , 2015 . Only one found that breathing was sustained postexercise by arm occlusion (Piepoli et al. 1995) . But this was not confirmed with postexercise leg occlusion (Scott et al. 2000) .
Recently, some (Lykidis et al. 2010; Bruce & White, 2012 , 2015 , but not all (see Fig. 1 of Olson, 2010) , have observed a small increase in breathing (4-7 l min −1 ) if cuff occlusion is combined with increasing the end-tidal partial pressure of carbon dioxide (P ET,CO 2 ) by ß7 mmHg in healthy subjects. There are a number of possible explanations for this.
Possibly, the unnatural stimulus of increasing P CO 2 (which does not occur as metabolic rate increases) simply exaggerates the breathing response to exercise. This is supported by the absence of this small stimulation if only the occluded limb is exposed to the raised P CO 2 (Bruce & White, 2015) .
Another possibility is that raising P ET,CO 2 compensates for incomplete muscle occlusion (i.e. for cuff leakage) and thereby at last provides a sufficiently intense stimulus to reveal a detectable increase in breathing. In any event, increases in breathing greater than 4-7 l min −1 need to be demonstrated before accepting the presence within muscle of chemoreceptors capable of making an important contribution to the control of breathing.
Inconclusive stimulation experiments for venous chemoreceptors in humans between muscle and the right heart
Here, the basic stimulation technique is to release venous blood (to release the postexercise occlusion cuff) containing trapped metabolites and/or drugs known to stimulate carotid chemoreceptors directly [e.g. cyanide (Winder et al. 1933; Anichkov & Belenkii, 1963; Comroe, 1964) ] and to measure the size and timing of any increase in breathing. Ideally, all four limbs are exercised at maximal intensity before all are occluded (to maximize the mass of trapped metabolites and thus any effect on breathing). If a convincing increase in breathing occurs after cuff release and before such blood could have reached the carotid chemoreceptors, then venous chemoreceptors must exist. But they may still exist even if breathing is stimulated only after this blood passes through the carotid chemoreceptors. There are two contradictory studies. Mills (1944) produced the first functional evidence that venous chemoreceptors might exist in humans. He applied a cuff for 10-15 min round one or two rested limbs. In 11 of 13 subjects, sudden release of the cuff produced a substantial stimulation of breathing (to a remarkable 16-92 l min −1 as measured in two subjects). Indeed, the stimulation was so intense that the resulting hypocapnia 'was sometimes so vigorous as to produce paraesthesia' (i.e. P aCO 2 levels <20 mmHg). This occurred 'within at most 4.2 sec' , which is too fast for the blood transport time as measured at rest (ß19 s) from limbs to the carotid chemoreceptors (Robb & Weiss, 1933; Dejours et al. 1955; Winning et al. 1986) . Furthermore, in some subjects, the chemoreceptor stimulant sodium cyanide was injected into the muscle distal to the occlusion immediately before release. On release (see Fig. 4 ), 'the hyperpnea was always diphasic' (in two subjects occurring at 2 and 11-13 s), with the first phase again being too fast to have stimulated carotid chemoreceptors. Astonishingly, nobody has ever attempted to confirm these remarkable results.
Instead, and without reference to Mills (1944) , Dejours et al. (1955) had only four subjects perform bilateral leg exercise at low intensity (only 14 W ew ), with the leg cuffs inflated for 2 min as exercise ended. Postexercise release of the cuff resulted in deoxygenated blood reaching the carotid region (earlobe) 17 s later (range 13-21 s), and in none did breathing increase until a mean of 2.5 ± 1 s after this (range 0.9-6.4 s). Figure 5 shows the results from one subject. Dejours cautiously concluded that this ' . . . seems to show the absence of ventilatory chemoreceptors situated along the path of the venous blood from the vena cava to the right heart' [my translation].
But there is more than one interpretation. Venous chemoreceptors could still exist but have a longer latency. Without carotid chemoreceptor denervation, this possiblity cannot be ruled out. Neither are these results compatible with those of Mills (1944) . Nor has anyone directly confirmed Dejours's results. Nor has anyone (Winning et al. 1986 ) confirmed Dejours's methodological claim, remarkable with apparatus of unspecified response time available in 1955, that they could even measure accurately the time course of the arrival at the earlobe of deoxygenated blood suddenly released from the leg! Instead of this discrepancy provoking new experiments to distinguish between the results of Mills (1944) and Dejours, it was Dejours who wrote the series of reviews (Dejours, 1962 (Dejours, , 1963 (Dejours, , 1964 , cautiously proposing that 'such chemoreceptors do not seem to exist' . In contrast, despite the study by Mills (1944) being published in a mainstream journal, this has been cited so rarely since that it is reasonable to describe it as new evidence. [Even when cited (Ross et al. 1962) , no confirmatory experiments were undertaken.] Subsequent studies in dogs confirm that cyanide stimulates breathing by stimulating something at an unknown location other than the arterial or central chemoreceptors. Levine (1975) found that intra-aortic cyanide stimulated breathing (by 228%) in eight anaesthetized dogs even after bilateral sino-aortic denervation in four of them (independently confirming the findings of Winder et al. 1933) . This stimulation cannot be attributable to cyanide directly stimulating the head, brain, arterial or central chemoreceptors because it still stimulated breathing (by 163%) in five dogs when their heads were vascularly isolated from the rest of their bodies. This could be explained by cyanide stimulating venous chemoreceptors.
Many subsequent papers in humans confirm that cuff release produces a sudden increase in breathing (Rowell et al. 1976; Fordyce et al. 1982; Innes et al. 1989; Haouzi et al. 1993 Haouzi et al. , 2001 Fukuba et al. 2007 ), without providing a complete or the same explanation, and without referencing Mills (1944) .
Inconclusive ablation experiments for a venous chemoreceptor spinal afferent pathway in humans
If venous chemoreceptors exist in peripheral veins, one obvious afferent pathway to the brain is via the spinal cord. If they are the crucial metabolic rate sensors and use this afferent pathway exclusively, this predicts that, if the spinal cord is blocked and the muscle below the cord can somehow be 'exercised' , breathing should now fail to increase in proportion to metabolic rate. Again, experiments so far are inconclusive (Dempsey et al. 2014) . Fernandes et al. (1990) had six subjects exercise at 57% of maximal oxygen uptake on a bicycle ergometer and up to exhaustion (ß238 ± 30 W ew ). They found that maximal metabolic rate (1 kW) and breathing (116 ± 11 l min −1 ) were not significantly different between control subjects and those with epidural anaesthesia at L3/L4. But the fact that they could continue pedalling at all shows that the spinal cord was not completely blocked! It is naïve to assume that epidural anaesthesia blocks all afferent but no efferent pathways. Furthermore, although pain sensation (to pin pricks) was lost, they demonstrated residual activity in one subconscious sensory pathway (Mills, 1944) Reproduced with permission from Mills (1944) .
(their Fig. 1 shows persistence of an 'attenuated' pressor response to leg ischaemia). Thus, it is not certain that all sensory pathsways were blocked and therefore that venous chemoreceptors cannot exist.
Likewise, if breathing increased normally in paraplegics during electrically evoked 'exercise' of the limbs below the spinal break, this too would oppose the existence of a spinal afferent pathway from venous chemoreceptors that drives breathing. Evidence for such 'exercise' stimulating breathing has been presented in humans (Adams et al. 1984; Brice et al. 1988; Brown et al. 1990 ) and in other mammals under anaesthesia (see Levine, 1979; Cross et al. 1982; Haouzi et al. 2005) . But there two problems. Firstly, the intensity of such artificial exercise is too low to be definitive [increasing breathing by only 2-4 l air min −1 ! (Adams et al. 1984; Brice et al. 1988; Brown et al. 1990) ]. Secondly, warmed blood returning from the exercising muscles will cross the spinal break, and thermal conduction may stimulate spinal thermoreceptors, whose stimulation could then explain the stimulation of breathing (Hales et al. 1970) .
Two other related techniques are likewise inconclusive. All that can be deduced from the fact that breathing still increases during modest exercise in humans after heart or heart lung transplantation (Banner et al. 1988) , or in those with left to right cardiac shunts (Storey & Butler, 1963) , is that venous chemoreceptors may not exist solely in the cardiopulmonary region.
The definitive studies still to be undertaken
It is straightforward to resolve the venous chemoreceptor question in humans [to distinguish between Mills (1944) and Dejours et al. (1955) ]. Bilateral carotid chemoreceptor denervation is still performed (Dahan et al. 2007 ). Definitive occlusion cuff-release experiments using the scientific method outlined above could be carried out on such patients. How fast (in relationship to limb-carotid conduction time) and by how much does release of an occlusion cuff round four maximally exercised limbs (preferably also containing a dye and/or cyanide) stimulate their breathing both before and after denervation?
In such patients, it should also be possible to establish whether any residual breathing sensitivity to hypoxia is attributable to arterial, venous or other chemoreceptors. What is the size of any stimulation of their breathing at suitable fractional inspired O 2 levels <9%? By how much is their breathing at rest stimulated if both their P vCO 2 and P vO 2 levels are changed to those seen during maximal exercise?
Conclusions
On the one hand, venous chemoreceptors cannot be discovered if they do not exist. But this has not been established definitively. If it is, the mystery deepens of how to explain the matching of breathing to metabolic rate without involving arterial, central or venous chemoreceptors. Then the many more complex hypotheses attempting to explain this (Comroe, 1964 (Comroe, , 1974 Dejours, 1964; Ward, 1994; Dempsey et al. 1995 Dempsey et al. , 2014 Waldrop et al. 1996; Forster & Pan, 1997; Dempsey & Whipp, 2003; Prabhakar & Peng, 2004; Poon et al. 2007; Forster, 2007 Forster, , 2014 Forster et al. 2012; Kumar & Prabhakar, 2012; Parkes, 2013; Paterson, 2014) require fresh ideas to investigate them. On the other hand, venous chemoreceptors might not have been found because the wrong stimulus has been applied at the wrong location for the wrong duration. If the ideal experiments ever reveal them, there is no inconsistency with current scientific literature. Then the many more complex hypotheses then become unnecessary. Venous chemoreceptors may have been present all the time, but we fail to see them.
